Effectiveness of BufferGel as a Vaginal Contraceptive - Contacts and Locations

Effectiveness of BufferGel as a Vaginal Contraceptive

This study has been completed.

Study NCT00065858. Last updated on June 21, 2006. Information provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065858

Locations


United States, California
	California Family Health Council
	Los Angeles, California, United States
	California Family Health Council
	Berkeley, California, United States

United States, Colorado
	University of Colorado
	Denver, Colorado, United States

United States, New York
	New York University
	New York, New York, United States
	Columbia University
	New York, New York, United States

United States, Ohio
	University of Cincinnati
	Cincinnati, Ohio, United States

United States, Pennsylvania
	University of Pennsylvania
	Philadelphia, Pennsylvania, United States
	University of Pittsburgh
	Pittsburgh, Pennsylvania, United States

United States, Virginia
	Eastern Virginia Medical School
	Norfolk, Virginia, United States

Sponsors and Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators


Study Director:	H. Trent MacKay, MD, MPH	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)